Madrigal Pharmaceuticals (MDGL) Non Operating Income (2010 - 2016)
Madrigal Pharmaceuticals (MDGL) posted quarterly Non Operating Income of $41778.0 for Q3 2016, up 104.54% year-over-year from $20425.1 in Q4 2015, and up 119.88% quarter-over-quarter from $19000.0 in Q2 2016.
Madrigal Pharmaceuticals (MDGL) Non Operating Income (2010 - 2016) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has reported Non Operating Income for 7 consecutive years, with $41778.0 the latest figure, recorded in Q3 2016.
- In Q3 2016, Non Operating Income rose 104.54% year-over-year to $41778.0; the TTM figure through Sep 2016 stood at -$172222.0 (up 91.59% YoY), while the FY2015 annual figure was -$1.1 million, up 51.99% from the prior year.
- Non Operating Income grew to $41778.0 in Q3 2016 per MDGL's latest filing, from $19000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $41778.0 in Q3 2016 and bottomed at -$1.4 million in Q3 2012.
- Historically, Non Operating Income has averaged -$521738.3 across 5 years, with a median of -$486000.0 in 2012.
- Annual changes were most pronounced in 2012 — Non Operating Income slumped 176.94% — and 2016, when it jumped 106.42%.
- Madrigal Pharmaceuticals' Non Operating Income stood at -$420000.0 in 2012, then plunged by 70.95% to -$718000.0 in 2013, then soared by 36.21% to -$458000.0 in 2014, then surged by 65.94% to -$156000.0 in 2015, then jumped by 126.78% to $41778.0 in 2016.
- Business Quant data shows MDGL's Non Operating Income at $41778.0 in Q3 2016, $19000.0 in Q2 2016, and -$77000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Madrigal Pharmaceuticals | 14.79 Bn | 13.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 41,778.00 |
| Jun 30, 2016 | 19,000.00 |
| Mar 31, 2016 | -77,000.00 |
| Dec 31, 2015 | -156,000.00 |
| Sep 30, 2015 | -919,805.00 |
| Jun 30, 2015 | -296,000.00 |
| Mar 31, 2015 | -375,000.00 |
| Dec 31, 2014 | -458,000.00 |
| Sep 30, 2014 | -517,000.00 |
| Jun 30, 2014 | -585,000.00 |
| Mar 31, 2014 | -650,000.00 |
| Dec 31, 2013 | -718,000.00 |
| Sep 30, 2013 | -721,000.00 |
| Jun 30, 2013 | -724,000.00 |
| Mar 31, 2013 | -470,000.00 |
| Dec 31, 2012 | -420,000.00 |
| Sep 30, 2012 | -1.43 Mn |
| Jun 30, 2012 | -972,000.00 |
| Mar 31, 2012 | -486,000.00 |
| Dec 31, 2011 | -504,000.00 |